BRC Moue E-mail News No. 183

************************************************************************
BRC Mouse E-mail News No. 183
************************************************************************

RIKEN BioResource Research Center (BRC) is pleased to update you with the 
latest information.

======= Contents =======================================================
- Today's tool for functional analysis
- User publications
- Newly deposited mouse strains
========================================================================

+-----------------------------------------------------------------------
| Today's tool for functional analysis
+-----------------------------------------------------------------------

Neuronal cells Cre-driver mice
RBRC11130 C57BL/6N-Tubb3<tm1.1(Cre)Ksak>

Spleen TLX1 expressing cells Cre-driver mice
RBRC11118 B6-Tlx1<tm1.1(cre/ERT2/ires2/Venus)Rygo>

Glucagon-producing α-cells Cre-driver mice
RBRC10958 C57BL/6-Gcg<em1(cre)Utr>

KRT19 expressing cells Cre-driver mice
RBRC10923 B6.B6D2-Tg(Krt19-icre)2Hirt

 https://mus.brc.riken.jp/en/todays_tool_and_model


+-----------------------------------------------------------------------
| User publications
+-----------------------------------------------------------------------

 The following result has been newly reported by users. We are
honored to introduce new publications to the science community.
Therefore, we look forward to receiving your publications too.
https://rrc.nbrp.jp/references/register

RBRC04944 B6.129S4-Il5<tm1.1Ktk>
Yamada T, Tatematsu M, Takasuga S, Fuchimukai A, Yamagata K, Seki S, Kuba K, 
Yoshida H, Taniuchi I, Bernhardt G, Shibuya K, Shibuya A, Yamada T, Ebihara T.
TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy.
J Exp Med. 2023 Jul 3;220(7):e20222005. doi: 10.1084/jem.20222005. 
https://doi.org/10.1084/jem.20222005

RBRC00144 B6.SJL-Ptprc<a>/Rbrc
Suga K, Suto A, Tanaka S, Sugawara Y, Kageyama T, Ishikawa J, Sanayama Y, Ikeda K, 
Furuta S, Kagami SI, Iwata A, Hirose K, Suzuki K, Ohara O, Nakajima H.
TAp63, a methotrexate target in CD4+ T cells, suppresses Foxp3 expression and 
exacerbates autoimmune arthritis.
JCI Insight. 2023 May 22;8(10):e164778. doi: 10.1172/jci.insight.164778. 
https://doi.org/10.1172/jci.insight.164778

RBRC09497 C57BL/6-Rag2<tm1Tgi>
Naito Y, Koyama S, Masuhiro K, Hirai T, Uenami T, Inoue T, Osa A, Machiyama H, 
Watanabe G, Sax N, Villa J, Kinugasa-Katayama Y, Nojima S, Yaga M, Hosono Y, 
Okuzaki D, Satoh S, Tsuda T, Nakanishi Y, Suga Y, Morita T, Fukushima K, Nishide M, 
Shiroyama T, Miyake K, Iwahori K, Hirata H, Nagatomo I, Yano Y, Tamiya M, Kumagai T, 
Takemoto N, Inohara H, Yamasaki S, Yamashita K, Aoshi T, Akbay EA, Hosen N, Shintani Y, 
Takamatsu H, Mori M, Takeda Y, Kumanogoh A.
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing 
CD8+ T cell cytotoxicity and proliferation.
Sci Adv. 2023 May 19;9(20):eade0718. doi: 10.1126/sciadv.ade0718.
https://doi.org/10.1126/sciadv.ade0718

RBRC01834 C57BL/6-Tg(CAG-flpe)36Ito/ItoRbrc
Fujinuma S, Nakatsumi H, Shimizu H, Sugiyama S, Harada A, Goya T, Tanaka M, Kohjima M, 
Takahashi M, Izumi Y, Yagi M, Kang D, Kaneko M, Shigeta M, Bamba T, Ohkawa Y, Nakayama KI.
FOXK1 promotes nonalcoholic fatty liver disease by mediating mTORC1-dependent inhibition of 
hepatic fatty acid oxidation.
Cell Rep. 2023 May 30;42(5):112530. doi: 10.1016/j.celrep.2023.112530. 
https://doi.org/10.1016/j.celrep.2023.112530

RBRC05555 B6;B6129-Ezh2<tm1Yugo>/Hko
Fukui Y, Hirota Y, Aikawa S, Sakashita A, Shimizu-Hirota R, Takeda N, Ishizawa C, 
Iida R, Kaku T, Hirata T, Hiraoka T, Akaeda S, Matsuo M, Osuga Y.
The EZH2-PRC2-H3K27me3 axis governs the endometrial cell cycle and differentiation 
for blastocyst invasion.
Cell Death Dis. 2023 May 18;14(5):320. doi: 10.1038/s41419-023-05832-x.
https://doi.org/10.1038/s41419-023-05832-x

RBRC00897 B6.Cg-Aicda<tm1Hon>(N10)/HonRbrc
Bello A, Müller A, Hirth G, Giebeler LN, Böttcher K, Voigt S, Jungnickel B.
Cell Cycle-Mediated Regulation of Secondary Ig Diversification.
J Immunol. 2023 May 15;210(10):1508-1518. doi: 10.4049/jimmunol.2100880.
https://doi.org/10.4049/jimmunol.2100880

RBRC10053 B6(Cg)-Aqp4<tm1.1Tsna>
Serizawa K, Miyake S, Katsura Y, Yorozu K, Kurasawa M, Tomizawa-Shinohara H, 
Yasuno H, Matsumoto Y.
Intradermal AQP4 peptide immunization induces clinical features of neuromyelitis 
optica spectrum disorder in mice.
J Neuroimmunol. doi: 10.1016/j.jneuroim.2023.578109.
https://doi.org/10.1016/j.jneuroim.2023.578109

RBRC02711 B6.129S-Osmr<tm1Mtan>
Feng Y, Yuan Y, Xia H, Wang Z, Che Y, Hu Z, Deng J, Li F, Wu Q, Bian Z, Zhou H, 
Shen D, Tang Q.
OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by 
modulating macrophages and OSM/LIFR/STAT3 signalling.
J Transl Med.  2023 Apr 29;21(1):290. doi: 10.1186/s12967-023-04163-x. 
https://doi.org/10.1186/s12967-023-04163-x

RBRC00144 B6.SJL-Ptprc<a>/Rbrc
Sumii Y, Kondo T, Ikegawa S, Fukumi T, Iwamoto M, Nishimura MF, Sugiura H, 
Sando Y, Nakamura M, Meguri Y, Matsushita T, Tanimine N, Kimura M, Asada N, 
Ennishi D, Maeda Y, Matsuoka KI.
Hematopoietic stem cell-derived Tregs are essential for maintaining favorable 
B cell lymphopoiesis following posttransplant cyclophosphamide.
JCI Insight. 2023 Apr 24;8(8):e162180. doi: 10.1172/jci.insight.162180.
https://doi.org/10.1172/jci.insight.162180

RBRC01346 C57BL/6-Prkdc<scid>/Rbrc
Kawase K, Kawashima S, Nagasaki J, Inozume T, Tanji E, Kawazu M, Hanazawa T, Togashi Y.
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to 
IFNγ Signaling Pathway Defects.
Cancer Immunol Res. 2023 Apr 16;OF1-OF14. doi: 10.1158/2326-6066.CIR-22-0815. 
https://doi.org/10.1158/2326-6066.CIR-22-0815

RBRC10014 B6D2;B6-Plcz1<em1Osb>
Hirose N, Kikuchi Y, Kageyama A, Sugita H, Sakurai M, Kawata Y, Terakawa J, 
Wakayama T, Ito J, Kashiwazaki N.
Successful Production of Offspring Derived from Phospholipase C Zeta-Deficient Sperm 
by Additional Artificial Activation.
Life (Basel). 2023 Apr 10;13(4):980. doi: 10.3390/life13040980.
https://doi.org/10.3390/life13040980

RBRC05582 C.Cg-Cpox<nct>/JmsRbrc
Read KA, Jones DM, Pokhrel S, Hales EDS, Varkey A, Tuazon JA, Eisele CD, 
Abdouni O, Saadey A, Leonard MR, Warren RT, Powell MD, Boss JM, Hemann EA, 
Yount JS, Xin G, Ghoneim HE, Lio CJ, Freud AG, Collins PL, Oestreich KJ.
Aiolos represses CD4+ T cell cytotoxic programming via reciprocal 
regulation of TFH transcription factors and IL-2 sensitivity.
Nat Commun. 2023;14:1652. doi: 10.1038/s41467-023-37420-0. 
https://doi.org/10.1038/s41467-023-37420-0


+-----------------------------------------------------------------------
| Newly deposited mouse strains
+-----------------------------------------------------------------------

Dr. Hiroshi Hamada, RIKEN BDR
RBRC11908 B6;Cg-Pycr2<tm1Hmd>
RBRC11941 B6;Cg-Pkd1l1<em1(mScarletI)Hmd>
RBRC11942 B6;Cg-Pkd1l1<em2(mScarletI)Hmd>

 https://mus.brc.riken.jp/en/mailnews/kitaku_list/20230522_k


__________________________________________________________________
*We hope you find the contents of this message of interest.
However, if you would prefer to unsubscribe from future e-mails, please
send an e-mail to animal.brc@riken.jp.
*If you have any questions or comments, please send an e-mail to
animal.brc@riken.jp.
*Content is subject to change without notice.
*All Rights Reserved.
__________________________________________________________________
RIKEN BioResource Research Center
Experimental Animal Division
3-1-1 Koyadai, Tsukuba-shi
Ibaraki, 305-0074 Japan
animal.brc@riken.jp
https://mus.brc.riken.jp/en/
__________________________________________________________________
2023.06.15.


Comments are closed.